The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma

Timothy G. Whitsett, Landon J. Inge, Nhan Tran

Research output: Contribution to journalArticle

Abstract

The high mortality rate in advanced lung cancer, due to a preponderance of tumors discovered at advanced stage, demands the discovery and clinical validation of biomarkers for diagnosing early stage disease. Quantitative proteomics technologies are capable of identifying protein biomarkers with diagnostic, prognostic, and predictive value. Recent works have demonstrated the utility in using quantitative proteomics across normal, pre-cancerous, and cancerous lesions towards the discovery of biomarkers for early stage lung cancer, as well as discovering novel mechanisms of lung carcinogenesis.

Original languageEnglish (US)
Pages (from-to)457-460
Number of pages4
JournalTranslational Lung Cancer Research
Volume2
Issue number6
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Proteomics
Squamous Cell Carcinoma
Biomarkers
Lung
Lung Neoplasms
Carcinogenesis
Technology
Mortality
Neoplasms
Proteins

Keywords

  • Glutathione s-transferase pi 1 (GSTP1)
  • Isobaric tags for relative and absolute quantitation (iTRAQ)
  • Lung squamous cell carcinoma
  • Proteomics

ASJC Scopus subject areas

  • Oncology

Cite this

The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma. / Whitsett, Timothy G.; Inge, Landon J.; Tran, Nhan.

In: Translational Lung Cancer Research, Vol. 2, No. 6, 2013, p. 457-460.

Research output: Contribution to journalArticle

@article{75a8adb33ae24803ac08275ebc0d1b4e,
title = "The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma",
abstract = "The high mortality rate in advanced lung cancer, due to a preponderance of tumors discovered at advanced stage, demands the discovery and clinical validation of biomarkers for diagnosing early stage disease. Quantitative proteomics technologies are capable of identifying protein biomarkers with diagnostic, prognostic, and predictive value. Recent works have demonstrated the utility in using quantitative proteomics across normal, pre-cancerous, and cancerous lesions towards the discovery of biomarkers for early stage lung cancer, as well as discovering novel mechanisms of lung carcinogenesis.",
keywords = "Glutathione s-transferase pi 1 (GSTP1), Isobaric tags for relative and absolute quantitation (iTRAQ), Lung squamous cell carcinoma, Proteomics",
author = "Whitsett, {Timothy G.} and Inge, {Landon J.} and Nhan Tran",
year = "2013",
doi = "10.3978/j.issn.2218-6751.2013.10.17",
language = "English (US)",
volume = "2",
pages = "457--460",
journal = "Translational Lung Cancer Research",
issn = "2226-4477",
publisher = "Society for Translational Medicine (STM)",
number = "6",

}

TY - JOUR

T1 - The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma

AU - Whitsett, Timothy G.

AU - Inge, Landon J.

AU - Tran, Nhan

PY - 2013

Y1 - 2013

N2 - The high mortality rate in advanced lung cancer, due to a preponderance of tumors discovered at advanced stage, demands the discovery and clinical validation of biomarkers for diagnosing early stage disease. Quantitative proteomics technologies are capable of identifying protein biomarkers with diagnostic, prognostic, and predictive value. Recent works have demonstrated the utility in using quantitative proteomics across normal, pre-cancerous, and cancerous lesions towards the discovery of biomarkers for early stage lung cancer, as well as discovering novel mechanisms of lung carcinogenesis.

AB - The high mortality rate in advanced lung cancer, due to a preponderance of tumors discovered at advanced stage, demands the discovery and clinical validation of biomarkers for diagnosing early stage disease. Quantitative proteomics technologies are capable of identifying protein biomarkers with diagnostic, prognostic, and predictive value. Recent works have demonstrated the utility in using quantitative proteomics across normal, pre-cancerous, and cancerous lesions towards the discovery of biomarkers for early stage lung cancer, as well as discovering novel mechanisms of lung carcinogenesis.

KW - Glutathione s-transferase pi 1 (GSTP1)

KW - Isobaric tags for relative and absolute quantitation (iTRAQ)

KW - Lung squamous cell carcinoma

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=84959868473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959868473&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2218-6751.2013.10.17

DO - 10.3978/j.issn.2218-6751.2013.10.17

M3 - Article

VL - 2

SP - 457

EP - 460

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

SN - 2226-4477

IS - 6

ER -